Yifan Pharmaceutical: the wholly-owned subsidiary received the notice of acceptance of drug consistency evaluation of emestine fumarate sustained-release capsules.

[Yifan Pharmaceutical: wholly-owned subsidiary receives acceptance notice for drug consistency evaluation of Emestine fumarate sustained-release capsules] FIFA News Agency, June 16, Sichuan Defeng Pharmaceutical Co., Ltd., a wholly-owned subsidiary, received an "acceptance notice" for drug consistency evaluation of domestic production of Emestine fumarate sustained-release capsules issued by the Drug Administration.